OAS2 and COVID-19: Both previously published RNA sequencing analysis of the same samples [11], and RT-qPCR experiments done for this project confirm that transcriptional products of IFI27 and OAS2 are upregulated in COVID-19 samples in comparison with non-COVID-19 control patients (Fig. 5A, B).